Cipher Pharmaceuticals (TSE:CPH) Stock Crosses Above Fifty Day Moving Average – Time to Sell?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$17.24 and traded as high as C$18.10. Cipher Pharmaceuticals shares last traded at C$17.87, with a volume of 20,443 shares.

Cipher Pharmaceuticals Stock Down 0.2%

The company has a debt-to-equity ratio of 4.36, a current ratio of 1.12 and a quick ratio of 2.67. The firm has a market capitalization of C$451.77 million, a PE ratio of 17.02 and a beta of 0.89. The company’s fifty day simple moving average is C$17.24 and its 200-day simple moving average is C$15.54.

Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) last issued its quarterly earnings results on Thursday, May 7th. The company reported C$0.33 earnings per share for the quarter. The business had revenue of C$17.39 million during the quarter. Cipher Pharmaceuticals had a return on equity of 24.23% and a net margin of 54.37%. On average, analysts forecast that Cipher Pharmaceuticals Inc. will post 1.2907348 EPS for the current year.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.